CASI logo

CASI Pharmaceuticals (CASI) Short Term Debt

Annual Short Term Debt

$728.00 K
-$140.00 K-16.13%

31 December 2023

CASI Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Short Term Debt

N/A

01 September 2024

CASI Quarterly Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CASI Short Term Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-16.1%-
3 y3 years-67.4%-
5 y5 years-51.4%-

CASI Short Term Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-67.4%at low
5 y5 years-67.4%
alltimeall time-91.5%

CASI Pharmaceuticals Short Term Debt History

DateAnnualQuarterly
Dec 2023
$728.00 K(-16.1%)
$728.00 K(-16.1%)
Dec 2022
$868.00 K(-18.2%)
$868.00 K(-77.9%)
Sept 2022
-
$3.92 M(+92.3%)
June 2022
-
$2.04 M(+106.2%)
Mar 2022
-
$989.00 K(-6.8%)
Dec 2021
$1.06 M(-52.4%)
$1.06 M(-2.1%)
Sept 2021
-
$1.08 M(-46.2%)
June 2021
-
$2.01 M(+1.2%)
Mar 2021
-
$1.99 M(-10.8%)
Dec 2020
$2.23 M(>+9900.0%)
$2.23 M(>+9900.0%)
Dec 2019
$0.00(-100.0%)
$0.00(-100.0%)
June 2019
-
$2.65 M(+76.5%)
Mar 2019
-
$1.50 M(+0.0%)
Dec 2018
$1.50 M(+97.9%)
$1.50 M(-0.0%)
Sept 2018
-
$1.50 M(+0.2%)
Sept 2017
-
$1.50 M(+0.1%)
June 2017
-
$1.50 M(+0.1%)
Mar 2017
-
$1.49 M(+0.5%)
Sept 2016
-
$1.49 M(+0.5%)
June 2016
-
$1.48 M(+0.5%)
Mar 2016
-
$1.47 M(+2.6%)
June 2015
-
$1.44 M(+1.6%)
Mar 2015
-
$1.41 M(-83.3%)
Mar 2012
-
$8.44 M(+1013.8%)
Dec 2010
$757.50 K(-91.1%)
$757.50 K(-74.6%)
Sept 2010
-
$2.98 M(-42.0%)
June 2010
-
$5.14 M(-29.0%)
Mar 2010
-
$7.24 M(-15.4%)
Dec 2009
$8.56 M(+11.0%)
$8.56 M(+11.0%)
Dec 2008
$7.71 M
$7.71 M(+2.6%)
Sept 2008
-
$7.51 M(+11.5%)
DateAnnualQuarterly
June 2008
-
$6.74 M(+39.3%)
Mar 2008
-
$4.83 M(+62.1%)
Dec 2007
$2.98 M(+297.0%)
$2.98 M(+153.3%)
Sept 2007
-
$1.18 M(+259.8%)
June 2007
-
$327.20 K(-39.7%)
Mar 2007
-
$542.70 K(-27.7%)
Dec 2006
$751.10 K(+1131.3%)
$751.10 K(-11.5%)
Sept 2006
-
$848.30 K(+3.4%)
June 2006
-
$820.40 K(+3.4%)
Mar 2006
-
$793.40 K(+1200.7%)
Dec 2005
$61.00 K(-98.7%)
$61.00 K(+131.1%)
Sept 2003
-
$26.40 K(-51.5%)
June 2003
-
$54.40 K(-25.6%)
Mar 2003
-
$73.10 K(-98.5%)
Dec 2002
$4.87 M(+383.7%)
$4.87 M(+273.8%)
Sept 2002
-
$1.30 M(+177.7%)
June 2002
-
$468.60 K(-36.7%)
Mar 2002
-
$740.50 K(-26.4%)
Dec 2001
$1.01 M(+0.9%)
$1.01 M(-6.4%)
Sept 2001
-
$1.07 M(+2.5%)
June 2001
-
$1.05 M(+2.5%)
Mar 2001
-
$1.02 M(+2.5%)
Dec 2000
$997.10 K(-11.4%)
$997.10 K(+2.3%)
Sept 2000
-
$974.60 K(+2.3%)
June 2000
-
$952.50 K(+2.3%)
Mar 2000
-
$930.90 K(-17.3%)
Dec 1999
$1.13 M(+1025.6%)
$1.13 M(+1025.6%)
Dec 1996
$100.00 K
$100.00 K(-50.0%)
Sept 1996
-
$200.00 K(-33.3%)
June 1996
-
$300.00 K(-25.0%)
Mar 1996
-
$400.00 K

FAQ

  • What is CASI Pharmaceuticals annual short term debt?
  • What is the all time high annual short term debt for CASI Pharmaceuticals?
  • What is CASI Pharmaceuticals annual short term debt year-on-year change?
  • What is the all time high quarterly short term debt for CASI Pharmaceuticals?

What is CASI Pharmaceuticals annual short term debt?

The current annual short term debt of CASI is $728.00 K

What is the all time high annual short term debt for CASI Pharmaceuticals?

CASI Pharmaceuticals all-time high annual short term debt is $8.56 M

What is CASI Pharmaceuticals annual short term debt year-on-year change?

Over the past year, CASI annual short term debt has changed by -$140.00 K (-16.13%)

What is the all time high quarterly short term debt for CASI Pharmaceuticals?

CASI Pharmaceuticals all-time high quarterly short term debt is $8.56 M